{"ORPHApacket":[{"ORPHApacketID":"364043","date":"2019-12-06 04:05:06","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"364043","Name":[{"lang":"en","label":"ALK-positive large B-cell lymphoma"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_364043","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Diffuse large B-cell lymphoma"}],"ORPHA":"544","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_544"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A very rare variant of diffuse large B-cell lymphoma (DLBCL) mainly affecting middle-aged immunocompetent men and characterized by a consistent primary involvement of lymph nodes (mainly in the cervical and mediastinum lymph nodes) and with infrequent extra nodal involvement of the bone marrow and other extra-nodal sites (head and neck region, liver, spleen, and gastrointestinal tract). It has an aggressive disease course, and is associated with a poor prognosis."}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Multigenic\/multifactorial"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"ALK+ LBCL"},{"lang":"en","label":"ALK+ large B-cell lymphoma"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"ALK receptor tyrosine kinase"}],"Symbol":"ALK","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"427"},{"Source":"OMIM","Reference":"105590"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317348","Name":[{"lang":"en","label":"Part of a fusion gene in"}]}]}]}]}]}